19.4 C
Lucknow
Online Latest News Hindi News , Bollywood News

India’s Cumulative COVID-19 Vaccination Coverage exceeds 181.21 Cr

English News

India’s COVID-19 vaccination coverage has exceeded 181.21 Cr (1,81,21,11,675) as per provisional reports till 7 am today. This has been achieved through 2,13,75,059 sessions.

COVID-19 vaccination for the age group 12-14 years was started on 16 March, 2022. So far, more than 17 lakh (17,36,464) adolescents have been administered with the first dose of COVID-19 vaccine.

The break-up of the cumulative figure as per the provisional report till 7 am today include:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 1,04,03,036
2nd Dose 99,90,377
Precaution Dose 43,58,282
FLWs 1st Dose 1,84,12,150
2nd Dose 1,74,88,506
Precaution Dose 66,63,768
Age Group 12-14 years 1st Dose 17,36,464
Age Group 15-18 years 1st Dose 5,62,03,581
2nd Dose 3,54,81,792
Age Group 18-44 years 1st Dose 55,37,77,249
2nd Dose 45,94,05,421
Age Group 45-59 years 1st Dose 20,26,11,031
2nd Dose 18,37,66,034
Over 60 years 1st Dose 12,66,42,354
2nd Dose 11,44,60,178
Precaution Dose 1,07,11,452
Precaution Dose 2,17,33,502
Total 1,81,21,11,675

Following a continuous downward trend, India’s Active Caseload has declined to 26,240 today, constituting 0.06% of the country’s total Positive Cases.

Consequently, India’s recovery rate stands at 98.74%.  3,196 patients have recovered in the last 24 hours and the cumulative tally of recovered patients (since the beginning of the pandemic) is now at 4,24,65,122.

1,761 new cases were reported in the last 24 hours.

The last 24 hours saw a total of 4,31,973 COVID-19 tests being conducted. India has so far conducted over 78.26 Cr (78,26,60,658) cumulative tests.

There has been a sustained fall in the weekly and daily Positivity Rates too. Weekly Positivity Rate in the country currently stands at 0.41% and the Daily Positivity rate is also reported to be 0.41%.

Related posts

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More